Comparative PK [Study Per­for­mance]

posted by PVRC – India, 2021-05-10 20:12 (1520 d 23:20 ago) – Posting: # 22338
Views: 5,094

Hi all,

For one of the product, the agency recommend to demonstrate comparative PK in the absence of bioequivalence. The question is that whether all bioequivalence criteria (like 80-125%, group effect etc.,) are still applicable to demonstrate comparative PK.

Thanks in advance....

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,689 registered users;
66 visitors (0 registered, 66 guests [including 9 identified bots]).
Forum time: 19:33 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5